Viking Global Investors LP Acadia Pharmaceuticals Inc Transaction History

Viking Global Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2015 May 15, 2015	SELL	N/A	-2,956,266 Closed	0 $0
Q4 2014 Feb 17, 2015	SELL	N/A	-1,368,624 Reduced 31.65%	2,956,266 $93.9 Million
Q3 2014 Nov 14, 2014	SELL	N/A	-432,988 Reduced 9.1%	4,324,890 $107 Million
Q2 2014 Aug 14, 2014	BUY	N/A	1,159,471 Added 32.22%	4,757,878 $107 Million
Q1 2014 May 15, 2014	BUY	N/A	967,762 Added 36.79%	3,598,407 $87.5 Million
Q4 2013 Feb 14, 2014	BUY	N/A	2,630,645	2,630,645 $65.7 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.